Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

UnitedHealth Group Stock (UNH) Opinions on Regulatory Scrutiny

None

Regulatory Scrutiny Intensifies: Social media chatter centers on state lawmakers pushing bills to curb UnitedHealth's involvement in pharmacy benefits and retail operations. Observers note this could reshape how major insurers handle prescriptions amid broader industry tensions. Analysts appear split on the potential fallout for the company's operations.

Medicare Pressures Surface: Recent posts flag concerns over Medicare funding stability and rising medical costs weighing on UnitedHealth's outlook. Some traders highlight short positions, anticipating further declines if utilization trends persist. Others point to Medicare Advantage growth as a counterbalance in ongoing debates.

Note: This discussion summary was generated from an AI condensation of post data.

UnitedHealth Group Insider Trading Activity

UNH Insider Trades

UnitedHealth Group insiders have traded $UNH stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $UNH stock by insiders over the last 6 months:

  • PATRICK HUGH CONWAY (Chief Executive Officer, Optum) sold 500 shares for an estimated $205,000

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

UnitedHealth Group Revenue

UNH Quarterly Revenue

UnitedHealth Group had revenues of $112B in Q2 2026. This is an increase of 0.37% from the same period in the prior year.

You can track UNH financials on Quiver Quantitative's UNH stock page.

You can access data on UNH stock through the Quiver Quantitative API.

UnitedHealth Group Congressional Stock Trading

Members of Congress have traded $UNH stock 13 times in the past 6 months. Of those trades, 8 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $UNH stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

UnitedHealth Group Hedge Fund Activity

We have seen 1,684 institutional investors add shares of UnitedHealth Group stock to their portfolio, and 1,559 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

UnitedHealth Group Price Targets

Multiple analysts have issued price targets for $UNH recently. We have seen 18 analysts offer price targets for $UNH in the last 6 months, with a median target of $434.5.

Here are some recent targets:

  • Ben Hendrix from RBC Capital set a target price of $463.0 on 07/09/2026
  • Sidharth Sahoo from HSBC set a target price of $380.0 on 07/06/2026
  • Erin Wright from Morgan Stanley set a target price of $468.0 on 06/30/2026
  • Kevin Fischbeck from B of A Securities set a target price of $475.0 on 06/24/2026
  • Whit Mayo from Leerink Partners set a target price of $462.0 on 06/17/2026
  • Lisa Gill from JP Morgan set a target price of $466.0 on 06/08/2026
  • Ann Hynes from Mizuho set a target price of $460.0 on 06/08/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles